Renovaro Biosciences Inc. (NASDAQ: RENB)
$1.41
+0.0100 ( +0.71% ) 143.7K
Renovaro Inc formerly Renovaro Biosciences Inc is a biopharmaceutical company. It is engaged in the research and development of pharmaceutical and biological products for the treatment of HIV, HBV, and cancer with the intent to manufacture said products.
Market Data
Open
$1.41
Previous close
$1.40
Volume
143.7K
Market cap
$218.58M
Day range
$1.39 - $1.45
52 week range
$0.66 - $5.25
SEC Fillings
| Form Type | Description | Pages | Date |
|---|---|---|---|
| 8-k | 8K-related | 18 | Feb 07, 2024 |
| 4 | Insider transactions | 1 | Feb 02, 2024 |
| 8-k | 8K-related | 13 | Jan 25, 2024 |
| 8-k | 8K-related | 12 | Jan 16, 2024 |
| 8-k | 8K-related | 42 | Jan 16, 2024 |
| prem14a | Proxies and info statements | 9 | Dec 22, 2023 |
| 8-k | 8K-related | 41 | Dec 01, 2023 |
| 10-q | Quarterly Reports | 62 | Nov 14, 2023 |
| 4 | Insider transactions | 1 | Nov 14, 2023 |
| 3 | Insider transactions | 1 | Nov 14, 2023 |